Newsletter | March 22, 2023

03.22.23 -- Optimize Product Life Cycles With A Collaborative Partnership Model

How Collaborative Value Engineering And Continuous Improvement Enhance The CDMO Relationship

Regular assessments of a partnership’s value in terms of supply chain, operational efficiency, data analysis, and more can optimize and extend the product life cycle. This need is particularly pressing for pharma companies operating in the generics or branded over-the-counter (OTC) spaces, since extending the product life cycle depends on lowering costs in response to competition-driven price pressure.

The Development, Scale-Up, And Manufacturing Of Semi-Solid Dosage Forms

Topical products, whether prescription dermatological drugs or over-the-counter lotions, creams, or gels, present unique challenges in terms of development and manufacturing. When faced with the many challenges of producing a safe, cost-effective, high-quality topical product, many companies will seek the expertise and experience of a CDMO partner.

The Advantages And Challenges Of Fixed-Dose Combination Products

Understanding both the significant competitive advantages that fixed-dose combination (FDC) products can offer and the difficulties and potential pitfalls associated with development and manufacturing of FDC drugs in oral solid dosage forms is a critical first step for companies exploring this approach. Explore considerations for design, formulation, manufacturing, and analysis.

Drug Product Development: Developing With Expertise

Specializing in executing all aspects of the CMC dosage form section of the NDA, our laboratories, pilot facilities, and experts are with you at every stage of the development process.

Request Information